Summary of case control studies on NQO1 Pro187Ser polymorphisms and lung, bladder, and colorectal cancer risk
First author . | Year of publication . | Country . | Control source . | Ethnicity . | Cases . | Frequency of CT/TT . | Controls . | Frequency of CT/TT . | Crude OR* (95% CI) . | Adjusted OR* (95% CI) . | Adjustment factors . | Ref. . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lung cancer | ||||||||||||||||||||||||
Lawson† | 2005 | Finland | Population based (nested case-control) | White | 353 | 0.31 | 360 | 0.33 | 0.93 (0.68-1.27) | 0.93 (0.67-1.28) | Age, no. cigarettes smoked, years smoked, and intervention assignment | (45) | ||||||||||||
Sorensen | 2005 | Denmark | Population based (case-cohort) | White | 256 | 0.36 | 269 | 0.34 | 1.13 (0.76-1.64)‡ | 1.11 (0.75-1.63)‡ | Duration of smoking | (40) | ||||||||||||
0.89 (0.36-2.20)§ | 0.90 (0.37-2.16)§ | |||||||||||||||||||||||
Skuladottir∥ | 2005 | Denmark | Mixed | White | 232 | 0.29 | 346 | 0.34 | 0.79 (0.53-1.20) | 0.74 (0.47-1.14) | Age, sex, and study | (39) | ||||||||||||
Alexandrie | 2004 | Sweden | Laboratory workers | White | 524 | 0.34 | 530 | 0.31 | 1.17 (0.90-1.52)‡ | 1.11 (0.76-1.60)‡ | Age and sex | (26) | ||||||||||||
1.30 (0.53-3.18)§ | 1.41 (0.45-4.36)§ | |||||||||||||||||||||||
Lewis | 2001 | United Kingdom | Hospital | White | 94 | 0.32 | 165 | 0.24 | 1.52 (0.83-2.77) | 1.31 (0.66-2.58) | Age, sex, and pack-year smoked | (32) | ||||||||||||
Xu | 2001 | United States | Friends/Family | White (97%) | 814 | 0.35 | 1,123 | 0.35 | 1.00 (0.83-1.21) | (16) | ||||||||||||||
Benhamou¶ | 2001 | France | Hospital | White | 150 | 0.43 | 172 | 0.39 | 1.20 (0.77-1.87) | 1.20 (0.70-2.0) | Age, sex, smoking, and occupation exposure | (27) | ||||||||||||
Hung | Unpublished** | Eastern Europe | Hospital | White | 2,224 | 0.33 | 2,279 | 0.33 | 1.04 (0.92-1.18) | (44) | ||||||||||||||
Lan | 2004 | China | Population based | Chinese | 119 | 0.69 | 109 | 0.71 | 0.92 (0.52-1.62) | 0.91 (0.51-1.62) | Sex and pack-year smoked | (31) | ||||||||||||
Liang | 2004 | China | Hospital | Chinese | 152 | 0.77 | 152 | 0.65 | 1.66 (1.01-2.74) | (33) | ||||||||||||||
Lin | 2003 | Taiwan | Hospital | Chinese | 198 | 0.71 | 332 | 0.71 | 0.99 (0.67-1.46) | 0.93 (0.63-1.23) | Age, sex, and smoking status | (36) | ||||||||||||
Yin | 2001 | China | Hospital | Chinese | 84 | 0.67 | 84 | 0.69 | 0.90 (0.47-1.71) | (43) | ||||||||||||||
Lin | 2000 | China | Hospital | Chinese | 95 | 0.87 | 136 | 0.70 | 2.89 (1.43-5.87) | (34) | ||||||||||||||
Sunaga†† | 2002 | Japan | Hospital | Japanese | 198 | 0.58 | 152 | 0.66 | 0.76 (0.48-1.20)‡ | 0.69 (0.67-0.72)‡ | Age, sex, and smoking status | (41) | ||||||||||||
0.60 (0.30-1.18)§ | 0.47 (0.22-0.97)§ | |||||||||||||||||||||||
Hamajima | 2002 | Japan | Hospital | Japanese | 192 | 0.55 | 640 | 0.63 | 0.72 (0.52-1.00) | 0.71 (0.50-1.0) | Age and sex | (30) | ||||||||||||
Saldivar | 2005 | United States | Private physician group | White | 683 | 0.34 | 683 | 0.30 | 1.19 (0.95-1.50) | 1.19 (0.95-1.50) | Age, sex, and smoking status | (38) | ||||||||||||
African American | 107 | 0.37 | 107 | 0.36 | 1.08 (0.62-1.89) | 1.08 (0.62-1.90) | ||||||||||||||||||
Hispanic | 36 | 0.58 | 36 | 0.58 | 1.00 (0.39-2.55) | 0.99 (0.38-2.58) | ||||||||||||||||||
Bock‡‡ | 2005 | United States | Population based | White | 130 | 0.28 | 144 | 0.40 | 0.61 (0.37-1.01) | 0.62 (0.37-1.05) | Age and sex | (28) | ||||||||||||
African American | 31 | 0.32 | 29 | 0.28 | 1.25 (0.41-3.79) | 0.78 (0.22-2.75) | ||||||||||||||||||
Chen | 1999 | United States, Hawaii | Population based | Japanese | 109 | 0.44 | 167 | 0.62 | 0.73 (0.44-1.22)‡ | 0.8 (0.4-1.5)‡ | Age, sex, ethnicity, smoking, saturated fat, and vegetable intake | (29) | ||||||||||||
0.33 (0.13-0.82)§ | 0.3 (0.1-0.7)§ | |||||||||||||||||||||||
White | 135 | 0.40 | 171 | 0.39 | 1.06 (0.67-1.68) | 0.8 (0.4-1.5) | ||||||||||||||||||
Hawaiian | 83 | 0.27 | 102 | 0.41 | 0.52 (0.28-0.96) | 0.6 (0.2-1.3) | ||||||||||||||||||
Wiencke | 1997 | United States | Community | African American | 116 | 0.34 | 136 | 0.39 | 0.79 (0.47-1.33) | (42) | ||||||||||||||
Hispanic | 61 | 0.52 | 161 | 0.68 | 0.53 (0.29-0.96) | |||||||||||||||||||
Bladder cancer | ||||||||||||||||||||||||
Broberg | 2005 | Sweden | Population based | White | 61 | 0.30 | 156 | 0.31 | 0.70 (0.35-1.43)‡ | 0.72 (0.34-1.50)‡ | Age, sex, and smoking | (46) | ||||||||||||
4.15 (0.95-18.12)§ | 3.90 (0.85-18.0)§ | |||||||||||||||||||||||
Terry | 2005 | United States | Hospital | Mostly White (>90%) | 235 | 0.34 | 214 | 0.30 | 1.19 (0.80-1.77) | 1.10 (0.70-1.70) | Age, sex, ethnicity, and smoking | (53) | ||||||||||||
Hung | 2004 | Italy | Hospital | White | 201 | 0.44 | 214 | 0.37 | 1.33 (0.90-1.97) | 1.32 (0.87-2.00) | Age, education, and pack-year smoked | (48) | ||||||||||||
Sanyal | 2004 | Sweden | Same geographic area | White | 299 | 0.31 | 124 | 0.33 | 0.91 (0.58-1.43) | (52) | ||||||||||||||
Park | 2003 | United States | Private physician group | White | 232 | 0.39 | 239 | 0.32 | 1.36 (0.93-1.99) | 1.51 (1.01-2.25) | Age, sex, and smoking status | (50) | ||||||||||||
Schulz | 1997 | Germany | University | White | 99 | 0.31 | 260 | 0.25 | 1.37 (0.82-2.28) | (54) | ||||||||||||||
Moore | 2004 | Argentina | Population based | Hispanic | 106 | 0.42 | 108 | 0.44 | 0.92 (0.54-1.58) | (49) | ||||||||||||||
Choi | 2003 | Korea | Hospital | Korean | 177 | 0.54 | 170 | 0.62 | 0.72 (0.47-1.10) | 0.63 (0.37-1.00) | Age, urinary track stones, and smoking | (47) | ||||||||||||
Colorectal cancer | ||||||||||||||||||||||||
van der Logt | 2005 | Netherlands | Population based | White | 371 | 0.39 | 415 | 0.30 | 1.52 (1.13-2.04) | 1.60 (1.03-2.40) | Age and sex | (59) | ||||||||||||
Mitrou | 2002 | United Kingdom | Screening trial | White | 206 | 0.36 | 345 | 0.33 | 1.18 (0.82-1.69) | 0.97 (0.65-1.46) | Age and sex | (57) | ||||||||||||
Sachse | 2002 | United Kingdom | Population based | White | 490 | 0.42 | 593 | 0.41 | 1.03 (0.81-1.31) | (58) | ||||||||||||||
Lafuente | 2000 | Spain | Hospital | White | 247 | 0.24 | 296 | 0.20 | 1.27 (0.85-1.91) | (56) | ||||||||||||||
Harth | 2000 | Germany | Population | White | 323 | 0.35 | 205 | 0.34 | 1.05 (0.73-1.52) | (55) | ||||||||||||||
Hamajima | 2002 | Japan | Hospital | Japanese | 146 | 0.58 | 640 | 0.63 | 0.84 (0.58-1.21) | 0.95 (0.58-1.57)§§ | Age and sex | (30) | ||||||||||||
0.74 (0.45-1.22)∥∥ |
First author . | Year of publication . | Country . | Control source . | Ethnicity . | Cases . | Frequency of CT/TT . | Controls . | Frequency of CT/TT . | Crude OR* (95% CI) . | Adjusted OR* (95% CI) . | Adjustment factors . | Ref. . | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lung cancer | ||||||||||||||||||||||||
Lawson† | 2005 | Finland | Population based (nested case-control) | White | 353 | 0.31 | 360 | 0.33 | 0.93 (0.68-1.27) | 0.93 (0.67-1.28) | Age, no. cigarettes smoked, years smoked, and intervention assignment | (45) | ||||||||||||
Sorensen | 2005 | Denmark | Population based (case-cohort) | White | 256 | 0.36 | 269 | 0.34 | 1.13 (0.76-1.64)‡ | 1.11 (0.75-1.63)‡ | Duration of smoking | (40) | ||||||||||||
0.89 (0.36-2.20)§ | 0.90 (0.37-2.16)§ | |||||||||||||||||||||||
Skuladottir∥ | 2005 | Denmark | Mixed | White | 232 | 0.29 | 346 | 0.34 | 0.79 (0.53-1.20) | 0.74 (0.47-1.14) | Age, sex, and study | (39) | ||||||||||||
Alexandrie | 2004 | Sweden | Laboratory workers | White | 524 | 0.34 | 530 | 0.31 | 1.17 (0.90-1.52)‡ | 1.11 (0.76-1.60)‡ | Age and sex | (26) | ||||||||||||
1.30 (0.53-3.18)§ | 1.41 (0.45-4.36)§ | |||||||||||||||||||||||
Lewis | 2001 | United Kingdom | Hospital | White | 94 | 0.32 | 165 | 0.24 | 1.52 (0.83-2.77) | 1.31 (0.66-2.58) | Age, sex, and pack-year smoked | (32) | ||||||||||||
Xu | 2001 | United States | Friends/Family | White (97%) | 814 | 0.35 | 1,123 | 0.35 | 1.00 (0.83-1.21) | (16) | ||||||||||||||
Benhamou¶ | 2001 | France | Hospital | White | 150 | 0.43 | 172 | 0.39 | 1.20 (0.77-1.87) | 1.20 (0.70-2.0) | Age, sex, smoking, and occupation exposure | (27) | ||||||||||||
Hung | Unpublished** | Eastern Europe | Hospital | White | 2,224 | 0.33 | 2,279 | 0.33 | 1.04 (0.92-1.18) | (44) | ||||||||||||||
Lan | 2004 | China | Population based | Chinese | 119 | 0.69 | 109 | 0.71 | 0.92 (0.52-1.62) | 0.91 (0.51-1.62) | Sex and pack-year smoked | (31) | ||||||||||||
Liang | 2004 | China | Hospital | Chinese | 152 | 0.77 | 152 | 0.65 | 1.66 (1.01-2.74) | (33) | ||||||||||||||
Lin | 2003 | Taiwan | Hospital | Chinese | 198 | 0.71 | 332 | 0.71 | 0.99 (0.67-1.46) | 0.93 (0.63-1.23) | Age, sex, and smoking status | (36) | ||||||||||||
Yin | 2001 | China | Hospital | Chinese | 84 | 0.67 | 84 | 0.69 | 0.90 (0.47-1.71) | (43) | ||||||||||||||
Lin | 2000 | China | Hospital | Chinese | 95 | 0.87 | 136 | 0.70 | 2.89 (1.43-5.87) | (34) | ||||||||||||||
Sunaga†† | 2002 | Japan | Hospital | Japanese | 198 | 0.58 | 152 | 0.66 | 0.76 (0.48-1.20)‡ | 0.69 (0.67-0.72)‡ | Age, sex, and smoking status | (41) | ||||||||||||
0.60 (0.30-1.18)§ | 0.47 (0.22-0.97)§ | |||||||||||||||||||||||
Hamajima | 2002 | Japan | Hospital | Japanese | 192 | 0.55 | 640 | 0.63 | 0.72 (0.52-1.00) | 0.71 (0.50-1.0) | Age and sex | (30) | ||||||||||||
Saldivar | 2005 | United States | Private physician group | White | 683 | 0.34 | 683 | 0.30 | 1.19 (0.95-1.50) | 1.19 (0.95-1.50) | Age, sex, and smoking status | (38) | ||||||||||||
African American | 107 | 0.37 | 107 | 0.36 | 1.08 (0.62-1.89) | 1.08 (0.62-1.90) | ||||||||||||||||||
Hispanic | 36 | 0.58 | 36 | 0.58 | 1.00 (0.39-2.55) | 0.99 (0.38-2.58) | ||||||||||||||||||
Bock‡‡ | 2005 | United States | Population based | White | 130 | 0.28 | 144 | 0.40 | 0.61 (0.37-1.01) | 0.62 (0.37-1.05) | Age and sex | (28) | ||||||||||||
African American | 31 | 0.32 | 29 | 0.28 | 1.25 (0.41-3.79) | 0.78 (0.22-2.75) | ||||||||||||||||||
Chen | 1999 | United States, Hawaii | Population based | Japanese | 109 | 0.44 | 167 | 0.62 | 0.73 (0.44-1.22)‡ | 0.8 (0.4-1.5)‡ | Age, sex, ethnicity, smoking, saturated fat, and vegetable intake | (29) | ||||||||||||
0.33 (0.13-0.82)§ | 0.3 (0.1-0.7)§ | |||||||||||||||||||||||
White | 135 | 0.40 | 171 | 0.39 | 1.06 (0.67-1.68) | 0.8 (0.4-1.5) | ||||||||||||||||||
Hawaiian | 83 | 0.27 | 102 | 0.41 | 0.52 (0.28-0.96) | 0.6 (0.2-1.3) | ||||||||||||||||||
Wiencke | 1997 | United States | Community | African American | 116 | 0.34 | 136 | 0.39 | 0.79 (0.47-1.33) | (42) | ||||||||||||||
Hispanic | 61 | 0.52 | 161 | 0.68 | 0.53 (0.29-0.96) | |||||||||||||||||||
Bladder cancer | ||||||||||||||||||||||||
Broberg | 2005 | Sweden | Population based | White | 61 | 0.30 | 156 | 0.31 | 0.70 (0.35-1.43)‡ | 0.72 (0.34-1.50)‡ | Age, sex, and smoking | (46) | ||||||||||||
4.15 (0.95-18.12)§ | 3.90 (0.85-18.0)§ | |||||||||||||||||||||||
Terry | 2005 | United States | Hospital | Mostly White (>90%) | 235 | 0.34 | 214 | 0.30 | 1.19 (0.80-1.77) | 1.10 (0.70-1.70) | Age, sex, ethnicity, and smoking | (53) | ||||||||||||
Hung | 2004 | Italy | Hospital | White | 201 | 0.44 | 214 | 0.37 | 1.33 (0.90-1.97) | 1.32 (0.87-2.00) | Age, education, and pack-year smoked | (48) | ||||||||||||
Sanyal | 2004 | Sweden | Same geographic area | White | 299 | 0.31 | 124 | 0.33 | 0.91 (0.58-1.43) | (52) | ||||||||||||||
Park | 2003 | United States | Private physician group | White | 232 | 0.39 | 239 | 0.32 | 1.36 (0.93-1.99) | 1.51 (1.01-2.25) | Age, sex, and smoking status | (50) | ||||||||||||
Schulz | 1997 | Germany | University | White | 99 | 0.31 | 260 | 0.25 | 1.37 (0.82-2.28) | (54) | ||||||||||||||
Moore | 2004 | Argentina | Population based | Hispanic | 106 | 0.42 | 108 | 0.44 | 0.92 (0.54-1.58) | (49) | ||||||||||||||
Choi | 2003 | Korea | Hospital | Korean | 177 | 0.54 | 170 | 0.62 | 0.72 (0.47-1.10) | 0.63 (0.37-1.00) | Age, urinary track stones, and smoking | (47) | ||||||||||||
Colorectal cancer | ||||||||||||||||||||||||
van der Logt | 2005 | Netherlands | Population based | White | 371 | 0.39 | 415 | 0.30 | 1.52 (1.13-2.04) | 1.60 (1.03-2.40) | Age and sex | (59) | ||||||||||||
Mitrou | 2002 | United Kingdom | Screening trial | White | 206 | 0.36 | 345 | 0.33 | 1.18 (0.82-1.69) | 0.97 (0.65-1.46) | Age and sex | (57) | ||||||||||||
Sachse | 2002 | United Kingdom | Population based | White | 490 | 0.42 | 593 | 0.41 | 1.03 (0.81-1.31) | (58) | ||||||||||||||
Lafuente | 2000 | Spain | Hospital | White | 247 | 0.24 | 296 | 0.20 | 1.27 (0.85-1.91) | (56) | ||||||||||||||
Harth | 2000 | Germany | Population | White | 323 | 0.35 | 205 | 0.34 | 1.05 (0.73-1.52) | (55) | ||||||||||||||
Hamajima | 2002 | Japan | Hospital | Japanese | 146 | 0.58 | 640 | 0.63 | 0.84 (0.58-1.21) | 0.95 (0.58-1.57)§§ | Age and sex | (30) | ||||||||||||
0.74 (0.45-1.22)∥∥ |
ORs are (C/T+T/T) vs C/C unless otherwise specified.
Males with a smoking history only.
OR C/T vs C/C.
OR T/T vs C/C.
Pooled study: all subjects under 60 years (non–small cell lung cancer).
Smokers only.
Study period: 1998-2002.
Adenocarcinoma only.
Never smokers only.
OR (C/T+T/T) vs C/C for colon cancer.
OR (C/T+T/T) vs C/C for rectum cancer.